Assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use

Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and medical diagnostics or screening kits comprised of reagents for medical diagnostics or screening use; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes

Clinical lab services, namely, medical lab services, DNA screening scientific lab services, chemical lab services

Pharmaceutical products for the treatment or prevention of cancer and immune-related diseases.

Research and development of pharmaceutical products.

Pharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro immunological and neuroendocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, Major Depressive Disorder, cognitive disorders, schizophrenia, and psychoses, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, Parkinson's disease, GBA1-mediated diseases, central nervous system [CNS] diseases, hormonal disorders, genetic disorders and movement diseases, disorders and conditions, tardive dyskinesia, dystonia, tics, Tourette syndrome; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions.

Pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; Pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment.

Scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; Scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; Product development of pharmaceutical substances and medicines; Pharmaceutical and medical research and development; Pharmaceutical testing services; Scientific laboratory services; Research laboratory services; Providing online non-downloadable software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical and treatment data in the field of medical research.

Pharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro immunological and neuroendocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, Major Depressive Disorder, cognitive disorders, schizophrenia, and psychoses, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, Parkinson's disease, GBA1-mediated diseases, central nervous system [CNS] diseases, hormonal disorders, genetic disorders and movement diseases, disorders and conditions, tardive dyskinesia, dystonia, tics, Tourette syndrome; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions.

Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease, multiple sclerosis, and myasthenia gravis and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries

Pharmaceutical research and development; Research and development services in the field of cell therapy

Genome editing reagents for research purposes; chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering; biochemicals and biologics, namely, engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, pharmaceutical research, agricultural biotechnology, diagnostics, and industrial biotechnology; engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research and analysis and diagnostics.

Pharmaceutical preparations, namely, cell therapy products utilizing T-cell therapy for use in treating disease; pharmaceuticals for the treatment of cancer; pharmaceutical preparations in the nature of genetically modified cells, namely genetically modified immune cells for use in human therapeutics and in the treatment of cancer; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations for the treatment of genetic conditions, namely, cancer, smoking cessation preparations and tissue repair preparations; engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use.

Scientific laboratory services, namely, testing, analysis, and evaluation of the goods and services of others to assure compliance with the pharmaceutical, medical and environmental industry standards; testing, analysis, and evaluation of the goods and services of others to assure compliance with the microbial, chemical, biochemical, bacteriological, biodegradation, and toxicology industry standards.

Clinical lab services, namely, medical lab services, DNA screening scientific lab services, chemical lab services.